Earnings season for the second quarter continues Thursday with more results. Tellabs, Inc. (NASDAQ:TLAB), Starbucks Corporation (NASDAQ:SBUX), Gilead Sciences, Inc. (NASDAQ:GILD), Olin Corporation (NYSE:OLN) and Bristol Myers Squibb Co. (NYSE:BMY) are all scheduled to report.

Q2 Earnings

Tellabs, Inc. (TLAB)

Analysts are expecting Tellabs, Inc. (NASDAQ:TLAB) to report losses per share of 2 cents on $210 million in revenue for the second quarter of the year. The company’s full-year losses are expected to be 2 cents on full-year revenue of $862 million.

Analyst expectations for Tellabs, Inc. (NASDAQ:TLAB) have remained steady over the last 90 days. The company’s last two quarterly reports have been roughly in line with consensus, although it posed a significant positive surprise in the third quarter of last year.

Starbucks Corporation (SBUX)

The general consensus for Starbucks Corporation (NASDAQ:SBUX) is that it will report 53 cents per share in earnings on $3.72 billion in revenue for its third fiscal quarter. Full-year earnings are projected to be $2.18 per share on full-year revenue of $14.9 billion.

The company’s last five earnings reports have been very close to consensus. The average earnings per share estimate of analysts reporting to Zacks has remained the same over the last 60 days.

Gilead Sciences, Inc. (GILD)

Analysts are expecting Gilead Sciences, Inc. (NASDAQ:GILD) to report second quarter earnings per share between 48 cents and 50 cents. Revenue is expected to be $2.66 billion for the quarter. Full year earnings are expected to be $2 on full-year revenue of $10.7 billion.

Gilead Sciences, Inc. (NASDAQ:GILD) missed consensus in the first quarter of the year, although it came out slightly ahead in each of the three quarters previously. The average earnings estimate of analysts reporting to Zacks has increased slightly within the last week from 47 to 48 cents.

Olin Corporation (OLN)

Analysts believe Olin Corporation (NYSE:OLN) will report second quarter earnings of 52 cents per share on revenue of $660 million. Full-year earnings are expected to be $2.13 on full-year revenue of $2.6 billion.

Four of the company’s last five earnings reports have been positive surprises. Estimates of analysts reporting to Zacks have fallen from 61 cents per share 90 days ago to 52 cents now.

Bristol Myers Squibb Co. (BMY)

Analysts are estimating that Bristol Myers Squibb Co. (NYSE:BMY) will report earnings of 44 cents per share on $4.1 billion for the second quarter of the year. Full-year earnings per share are projected to be $1.80 on full-year revenue of $16.4 billion.

Two of Bristol Myers Squibb Co. (NYSE:BMY)’s last four earnings reports have been slight misses, although it surprised to the positive in one of the last four. In the second quarter of last year, the company was in line with consensus.